Evaluation of renal cancer progression in a mouse model of heart failure
Main Authors: | Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Cancer Communications |
Online Access: | https://doi.org/10.1002/cac2.12185 |
Similar Items
-
Transforming heart failure and cardio‐oncology care during COVID‐19
by: Valentina Bracun, et al.
Published: (2020-12-01) -
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
by: van Gilst Wiek H, et al.
Published: (2011-09-01) -
Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice
by: Joseph Pierre Aboumsallem, et al.
Published: (2019-03-01) -
Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice
by: Mudit Mishra, et al.
Published: (2018-10-01) -
Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
by: Eline L Vegter, et al.
Published: (2017-01-01)